From the Department of Neurology and Neurosurgery,
Montreal Neurological Institute, McGill University, Montreal, QC,
H3A 2B4, Canada, the § Department of Pharmacology,
University of Wisconsin, Madison, Wisconsin 53706, the
Department of Anatomy and Cell Biology, McGill University,
Montreal, QC, H3A 2B4, Canada, and the ** Department of Pharmacology,
University of North Carolina, Chapel Hill, North Carolina 27599
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We recently identified and cloned intersectin, a
protein containing two Eps15 homology (EH) domains and five Src
homology 3 (SH3) domains. Using a newly developed intersectin antibody, we demonstrate that endogenous COS-7 cell intersectin localizes to
clathrin-coated pits, and transfection studies suggest that the EH
domains may direct this localization. Through alternative splicing in a
stop codon, a long form of intersectin is generated with a C-terminal
extension containing Dbl homology (DH), pleckstrin homology (PH), and
C2 domains. Western blots reveal that the long form of intersectin is
expressed specifically in neurons, whereas the short isoform is
expressed at lower levels in glia and other nonneuronal cells.
Immunofluorescence analysis of cultured hippocampal neurons reveals
that intersectin is found at the plasma membrane where it is
co-localized with clathrin. Ibp2, a protein identified based on its
interactions with the EH domains of intersectin, binds to clathrin
through the N terminus of the heavy chain, suggesting a mechanism for
the localization of intersectin at clathrin-coated pits. Ibp2 also
binds to the clathrin adaptor AP2, and antibodies against intersectin
co-immunoprecipitate clathrin, AP2, and dynamin from brain extracts.
These data suggest that the long and short forms of intersectin are
components of the endocytic machinery in neurons and nonneuronal cells.
The Eps15 homology (EH)1
domain is an important protein-protein interaction module functioning
in endocytosis. The core of the EH domain-binding motif is composed of
the amino acids asparagine-proline-phenylalanine (NPF) (1-3). This
sequence is often found at the C terminus of EH domain-binding proteins
where the free carboxylate can contribute to binding (3). The EH domain
was originally identified in the epidermal growth factor receptor
phosphorylation substrate Eps15 (4). Through its EH domains, Eps15
binds to epsin, a recently identified protein implicated in endocytosis
(5). Eps15 is localized to the rim of clathrin-coated pits (6), likely
through its interactions with AP2 (7-10) and/or with epsin (5). EH
domains are also found in the yeast proteins Pan1p and End3p, which are
required for endocytosis and normal organization of the actin
cytoskeleton (11-15).
The Src homology 3 (SH3) domain, a 50-70-amino acid motif that binds
to proline-rich ligands (16, 17) has also been implicated in
endocytosis (18). For example, amphiphysins I and II are nerve
terminal-enriched proteins that demonstrate SH3
domain-dependent binding to proline-rich sequences in
dynamin and synaptojanin (19-23), enzymes which function in the
endocytosis of clathrin-coated vesicles (20, 24, 25). In fact,
overexpression of the SH3 domains of amphiphysins I and II leads to a
functional block in endocytosis in a number of different systems
(26-29).
A link between EH and SH3 domain-mediated protein-protein interactions
has been revealed with the identification and cloning of Xenopus
laevis intersectin, a protein containing two N-terminal EH
domains, a central helix forming region that has a high probability of
forming coiled-coil interactions, and five C-terminal SH3 domains (3).
Intersectin is homologous to Dap160, a Drosophila protein with two EH domains and four SH3 domains that was identified based on
its affinity for dynamin (30). Through this unique combination of
protein-protein interaction modules, intersectin has the potential to
form macromolecular complexes between EH domain- and SH3 domain-binding proteins. A human form of intersectin has also been recently identified through genomic analysis of chromosome 21 (31). Interestingly, those
authors determined that intersectin undergoes alternative splicing in
the stop codon leading to a short form (intersectin-s), which has the
same domain structure as the Xenopus protein, and a long
form (intersectin-l) that contains a C-terminal extension with
Dbl Homology (DH), Pleckstrin
Homology (PH), and C2 domains (31).
In this manuscript, we have generated an antibody against the EH
domains of frog intersectin which we have used to characterize the
expression and localization of the antigenically related mammalian protein. Western blots reveal that intersectin-s is expressed in a wide
variety of tissues and cell lines, including in COS-7 cells, where it
localizes to clathrin-coated pits on the plasma membrane. Transfection
studies suggest that the EH domains may mediate this localization.
Intersectin-l is expressed predominately in neurons where it is also
co-localized with clathrin. We previously identified two related
proteins that bind to the EH domains of intersectin:
intersectin-binding protein (Ibp)1, the mouse homologue of epsin (5),
and Ibp2 (3). Here, we demonstrate that Ibp2 binds to clathrin and AP2,
suggesting that it may be involved in the localization of intersectin
at clathrin-coated pits. In fact, clathrin, AP2, and dynamin were found
to co-immunoprecipitate with intersectin. Taken together, these data
suggest that both the short and long alternatively spliced forms of
intersectin are components of the molecular machinery for endocytosis
in nonneuronal cells and neurons.
Antibodies--
To generate an intersectin antibody, a
full-length intersectin cDNA clone from X. laevis (3)
was used as a template in PCR reactions with Pfu DNA
polymerase (Stratagene) with the forward primer
5'-CTGTGCGGATCCAATTTGGACATCTGGGCCATAACG and the reverse primer
5'-CTGTGGAATTCAAGATGGGGGAATATACTCTGGAGG. The PCR product, encoding amino acids 11 to 306 of intersectin, including both EH
domains (3), was cloned into the BamHI-EcoRI
sites of pGEX-2T (Amersham Pharmacia Biotech) and pTrcHisA
(Invitrogen). The resulting GST (GST-EHa/b) and His6
(His6-EHa/b) fusion proteins were expressed and purified as
described (19, 32). Two rabbits (2173, 2174) were injected with
approximately 50 µg of GST-EHa/b using Titermax adjuvant (CytRx
Corp.) with standard protocols. Antibody production was monitored by
Western blots against His6-EHa/b, and antibodies were
affinity purified using strips of polyvinylidene difluoride membrane
containing the same fusion protein (33). For preabsorption experiments,
2173 serum was diluted in phosphate-buffered saline (20 mM
NaH2PO4, 0.9% NaCl, pH 7.4) containing 1%
bovine serum albumin and incubated overnight at 4 °C with either GST
or His6-EHa/b immobilized on polyvinylidene difluoride
membranes. A polyclonal antibody against clathrin (34) and monoclonal
antibody AC1-M11 against Transfections of COS-7 Cells with Intersectin Constructs--
A
cDNA construct encoding hemagglutinin-tagged full-length
intersectin was prepared by PCR using an intersectin cDNA template with Pfu DNA polymerase and the following primers (F stands
for forward and R stands for reverse): intersectinFa
(5'-GATCCATGGCTCAGTTTGGAACTCCG); intersectinFb
(5'-CATGGCTCAGTTTGGAACTCCG); intersectinRa
(5'-GATCCCAGTTGTTAAAGCTGTAGGGT); and intersectinRb
(5'-CCAGTTGTTAAAGCTGTAGGGT). One PCR reaction was performed with the
primer pair intersectinFa with intersectinRb, and a second reaction
used intersectinFb with intersectinRa. The two reaction products were
mixed, and the double-stranded DNA was denatured and allowed to
re-anneal; one-fourth of the re-annealed molecules contain sticky ends
that are compatible for ligation to a BamHI cleaved vector.
The re-annealed mixtures were ligated into the pCGN-Hygro mammalian
expression vector which carries a BamHI site in-frame with
the epitope tag. Constructs encoding the EH domains (amino acids
11-306) were prepared in an identical manner using the following
primers: EHFa (5'-GATCCAATTTGGACATCTGGGCCATA); EHFb
(5'-CAATTTGGACATCTGGGCCATA); EHRa
(5'-GATCCAGATGGGGGAATATACTCTGG); and EHRb
(5'-CAGATGGGGGAATATACTCTGG). The constructs were verified by sequence
analysis and transfected into COS-7 using the calcium phosphate
precipitation method (36).
Preparation and Examination of Plasma Membranes--
COS-7 cells
were platted into tissue culture wells containing 22-mm coverslips
previously coated with poly-L-lysine. To coat the
coverslips, poly-L-lysine stock (Sigma) was diluted 1:100 in 0.15 M boric acid, pH 8.4, filter sterilized, and
incubated over coverslips for 30 min. After incubation, coverslips were washed extensively with sterile water and once with COS-7 cell medium.
Plasma membranes were prepared from the cells (either transfected or
nontransfected) essentially as described (37). Briefly, the cells were
maintained for 1 h at 4 °C and were then washed and sonicated
in 12 ml of buffer A (25 mM HEPES, pH 7.0, containing 25 mM KCl, 2.5 mM magnesium acetate, and 0.2 mM dithiothreitol) for 2 s using a 1/2-inch tapered
horn 1 cm above the coverslip at setting 5.0 (Sonics Materials Vibra
Cell). The cells were then washed three times in buffer A and fixed in
buffer B (20 mM HEPES, pH 6.8, 100 mM KCl, 5 mM MgCl2, 3 mM EGTA, and 3%
paraformaldehyde). Following fixation, coverslips were washed in
phosphate-buffered saline before being processed for immunofluorescence analysis.
Analysis of Tissue and Subcellular Distribution--
Postnuclear
supernatants from different tissues and cell lines were prepared and
processed for Western blots as described (22). Rat medial septal
neurons were prepared as described (38) as were glial cells from rat
hippocampus (39). To examine the subcellular distribution of
intersectin in neurons, dissociated cell cultures were prepared from
the CA3 and dentate regions of hippocampi from P1 rat pups as described
(40). Cells were maintained in culture from 1-7 days before processing
for immunofluorescence analysis. Images were captured with a Zeiss
scanning laser confocal microscope 410.
Binding Assays--
A GST fusion protein, encoding the
C-terminal 511 amino acids of Ibp2 (GST-Ibp2), was prepared by PCR from
an Ibp2 cDNA template (3) using Pfu DNA
polymerase (Stratagene) with the forward primer
5'-CTGTGCGGATCCTCAAGCAAGGCACTGACACTG and the reverse primer 5'-CTGATGAATTCCTCACTAGAGAAGGAAAGGGTT. The resulting PCR product was subcloned into the BamHI-EcoRI sites of
pGEX-2T (Amersham Pharmacia Biotech). GST-Ibp2 was expressed and
purified as described previously (32), except that the plasmid was
transformed into BL21 Escherichia coli, and the cells were
grown and induced at 30 °C. GST-Ibp2 was used in binding assays with
a Triton X-100 soluble rat brain extract as described (22). For
immunoprecipitation analysis, rat brain synaptosomes were resuspended
to a protein concentration of approximately 10 mg/ml in buffer C (20 mM HEPES, pH 7.4, 128 mM NaCl, 3 mM
KCl, 1.2 mM MgCl2, 0.1 mM
CaCl2, 11 mM glucose) and incubated for 1 h at 37 °C. Synaptosomal membranes were then pelleted, resuspended
in buffer D (20 mM HEPES, pH 7.4, 50 mM
NaPO4, pH 7.4, 0.1% Triton X-100, 5 mM EDTA, 5 mM EGTA, 50 mM Na-pyrophosphate, 50 mM Na-fluoride, 10 µg/ml PMSF), and disrupted by
sonication. The samples were spun in a microcentrifuge at maximal
velocity, and the supernatants were incubated with anti-intersectin
antisera (2173, 2174), pre-coupled to protein A-Sepharose. Following an
overnight incubation at 4 °C, the beads were washed in buffer D, and
proteins were recovered with SDS gel sample buffer.
Binding of Biotinylated Ibp2 and MP90 to Clathrin Terminal
Domain--
cDNA clones encoding Ibp2 (3), MP90 (Ref. 41; generous
gift of Dr. Todd Stukenberg, Harvard Medical School), and Luciferase (Promega Co.) were in vitro transcribed and translated in
the presence of biotinylated lysine tRNA using the TransendTM
nonradioactive translation detection system (Promega Co.) according to
the manufacturer instructions. The biotinylated proteins were diluted
in phosphate-buffered saline and incubated overnight at 4 °C with
GST fusion proteins, encoding the amino-terminal 579 amino acids of the
clathrin heavy chain (Ref. 42; generous gift of James Keen, Kimmel
Cancer Institute) or the amino acids NPFL (3), pre-bound to
glutathione-Sepharose. The beads were subsequently pelleted by
microcentrifugation and washed three times in 1 ml of
phosphate-buffered saline, and the bound proteins were eluted with SDS
gel sample buffer and prepared for Western blot analysis using
streptavidin conjugated to alkaline phosphatase.
Intersectin Localizes to Clathrin-coated Pits--
We have
recently identified and cloned X. laevis intersectin, a
novel protein composed of multiple EH and SH3 domains, protein modules
implicated in endocytosis (3). To explore the subcellular localization
of mammalian intersectin, we raised two rabbit polyclonal antisera
(2173, 2174) against the tandem EH domains of the frog protein because
the primary structures of this region are highly related
(i.e. 87% identical). We then used the 2173 antibody for immunofluorescence analysis of plasma membranes prepared from COS-7
cells using a procedure that leads to membranes rich in clathrin-coated
pits (37, 43, 44). In double-labeling experiments, antiserum 2173 yielded a bright, punctate staining pattern that was virtually
identical to the pattern seen for clathrin (Fig. 1A). The specificity of the
staining was confirmed by pre-absorption experiments. Both untreated
and GST preabsorbed antisera yielded bright, punctate staining, whereas
staining was virtually undetectable using antiserum preabsorbed against
the EH domains (Fig. 1B). Affinity purified antibodies
demonstrated an identical immunofluorescence pattern as untreated
antiserum (data not shown).
To begin to explore the mechanism of intersectin targeting, we
performed immunofluorescence analysis on plasma membranes prepared from
COS-7 cells transfected with recombinant full-length intersectin. At
the level of exposure used for Fig.
2A (~300 msec integration using a Sony CCD video camera), membranes from transfected cells, which
represent approximately 10% of the clathrin-positive membranes, were
strongly positive with antibody 2173. Endogenous intersectin, which is
weakly detectable in the nontransfected cells at this level of exposure
(Fig. 2A), is readily detectable upon longer exposures (~3
s integration; see Fig. 1). Interestingly, a similar staining pattern
was observed in COS-7 cells transfected with a construct encoding the
two EH domains of intersectin (amino acids 11 to 306) (Fig.
2A). By Western blot, both constructs were seen to be highly
overexpressed (data not shown). At higher magnification, double-labeling immunofluorescence revealed nearly complete
co-localization of both full-length intersectin and its EH domains with
clathrin-coated pits on the plasma membrane (Fig. 2B). Taken
together, the data in Figs. 1 and 2 suggest that intersectin is
localized to clathrin-coated pits, possibly through its EH domains,
although a role for the SH3 domains in membrane targeting cannot be
ruled out.
Expression of Intersectin Isoforms in Mammalian Cells--
To
further explore the expression of intersectin, we used affinity
purified antibody 2173 for Western blots of a crude rat brain extract.
Two bands of immunoreactivity were evident (Fig. 3A), 190 kDa (intersectin-l)
and 145 kDa (intersectin-s) in size. The molecular masses of these
bands are in good agreement with the predicted molecular masses of the
long (195, 576 Da) and short (137, 711 Da) isoforms of human
intersectin, alternatively spliced variants identified through genomic
analysis of chromosome 21 (31). To confirm the identity of these bands,
we performed in vitro binding assays using a fusion protein
encoding a region of the intersectin-binding protein, Ibp2, which
contains the NPF repeats that interact with the EH domains of
intersectin (3). Both the 190 and the 145 kDa species bind to the
fusion protein, suggesting that they are intersectin-l and
intersectin-s, respectively (Fig. 3b). This result is
further strengthened by the observation that both species also bind
specifically to a GST fusion protein encoding the peptide sequence NPFL
(data not shown). Western blot analysis of extracts from a wide variety
of tissues and cell lines demonstrates that intersectin-l is expressed
predominately in the brain, whereas intersectin-s is ubiquitously
expressed (Fig. 4). Interestingly,
intersectin-l is expressed in neurons and is not detected in glia (Fig.
3A). Intersectin-s is expressed in glia, and the low levels
of intersectin-s seen in neuronal cultures is likely because of glia
contamination of the neurons (Fig. 3A, Ref. 38). Also of
interest, the pheochromocytoma cell line, PC12, expresses intersectin-s
(Fig. 4), whereas intersectin-l was only weakly detectable, even after
NGF-induced differentiation (data not shown).
Localization of Intersectin in Neurons--
To explore the
subcellular localization of intersectin, we performed
immunofluorescence analysis of hippocampal neurons in culture using
confocal microscopy (45). Intersectin immunoreactivity appeared as
small spots, 0.5-1.0 µm in diameter, which were located within cell
bodies in Golgi-like structures, at the plasma membrane and throughout
the length of axons and dendrites (Fig.
5, upper left and bottom
panels). These intersectin punctae corresponded to regions
enriched in clathrin (Fig. 5), although not all intersectin positive
punctae were positive for clathrin (note the red staining in
the top right panel).
Intersectin Interacts Indirectly with Components of Clathrin-coated
Pits--
Through its EH domains, intersectin binds through the NPF
tripeptide with Ibp1 and Ibp2 (3). Interestingly, Ibp1 and Ibp2 also
contain the peptide sequences LVDLD and LVNLD, respectively, which
resemble clathrin-binding motifs (18, 46-48). To determine whether the
Ibps interact with clathrin, we generated a GST fusion protein encoding
the C-terminal 511 amino acids of Ibp2 (GST-Ibp2) that includes the
three NPF repeats and the LVNLD sequence (despite repeated attempts, we
were unable to generate soluble GST fusion proteins encoding Ibp1).
When incubated with rat brain extracts, GST-Ibp2 bound specifically to
clathrin (Fig. 6A). Consistent with the previous observation that epsin binds to AP2 (5), Ibp2 also
bound to AP2, as assessed by Western blots with an antibody to the
Several clathrin-binding proteins, including arrestin3 (42),
interact with clathrin through the N terminus of its heavy chain, a
region known as the terminal domain (49). To determine whether the
terminal domain is responsible for the binding of the Ibps, we tested
the binding of Ibp2 and MP90, a related mitotic phosphoprotein (41),
prepared in vitro by coupled transcription and translation,
to a GST fusion protein encoding the amino-terminal 579 amino acids of
the clathrin heavy chain. Both Ibp2 and MP90 bound to the N-terminal
fusion protein, whereas neither protein bound to a control GST fusion
to the peptide NPFL (Fig. 6B). Further, the negative control
protein, luciferase, bound to neither GST fusion protein (Fig.
6B). Thus, both Ibp2 and MP90 bind to the terminal domain of clathrin.
To further characterize the interaction of intersectin with
clathrin-coated pit components, we performed immunoprecipitation analysis from rat brain synaptosomes using antibodies against intersectin. Anti-intersectin antisera from two different rabbits (2173 and 2174) both immunoprecipitated intersectin-l and intersectin-s (Fig.
7). Both clathrin and AP2 were also
co-immunoprecipitated with intersectin as assessed with specific
antibodies (Fig. 7). Further, dynamin was also observed to
co-immunoprecipitate with the intersectin antibodies, but synaptojanin
did not under these conditions (Fig. 7). Thus, intersectin interacts
in vivo with distinct components of the endocytic
machinery.
We have recently identified and cloned X. laevis
intersectin, a protein containing two EH and five SH3 domains (3).
Intersectin is related to a Drosophila protein, Dap160 (30),
and is highly similar (81% identical) to human intersectin that was
cloned based on genomic analysis of chromosome 21 (31). Of interest,
human intersectin undergoes alternative splicing in the stop codon, leading to a short form with the same domain structure as the frog
protein and a long form with a C-terminal extension containing DH, PH,
and C2 domains (31).
The presence of EH and SH3 domains in proteins involved in endocytosis
(4, 18) provided the first suggestion that intersectin may function in
the endocytic process. Support for this idea then came from the
observation that frog intersectin and fruit fly Dap160 display SH3
domain-dependent binding to dynamin (3, 30), an enzyme that
functions in the formation of clathrin-coated vesicles (24, 25). To
begin to study the role of intersectin in mammalian cells, we generated
a polyclonal antibody against the EH domains of frog intersectin.
Analysis of intact cells in culture revealed a punctate, surface
staining for intersectin that was reminiscent of clathrin-coated pits
(data not shown). To explore this further, we prepared plasma membranes
from COS-7 cells using a procedure that leads to plasma membranes rich
in clathrin-coated pits (37, 43, 44). Immunostaining of these preparations revealed that intersectin is highly co-localized with
clathrin. As COS-7 cells only express intersectin-s, protein domains
contained within this splice variant (i.e. EH and SH3 domains, coiled-coil region) must be sufficient to direct targeting of
the molecule to clathrin-coated pits. To begin to address this, we
transfected COS-7 cells with full-length recombinant intersectin as
well as with a construct encoding just the tandem EH domains. Both
constructs localize to clathrin-coated pits, suggesting that the EH
domains are sufficient to mediate the subcellular localization of
intersectin-s. However, we cannot yet rule out a role for the SH3
domains in this process. For example, SH3 domains can function in
directing protein localization (18, 50), and intersectin-s could
potentially target to clathrin-coated pits through SH3
domain-dependent interactions with dynamin (3).
Western blot analysis reveals that intersectin-s is ubiquitously
expressed, whereas intersectin-l is expressed predominately in brain.
This agrees with Northern blots demonstrating two transcripts for human
intersectin, a 5.3-kilobase ubiquitously expressed transcript and an
approximately 15-kilobase brain-specific transcript (31). Although we
do not currently have an intersectin-l specific antibody, Western blots
suggest that intersectin-l is the major variant expressed in neurons.
Using confocal microscopy, we determined that intersectin is expressed
at the plasma membrane of rat hippocampal neurons in culture where it
is co-localized with clathrin. Thus, like intersectin-s, intersectin-l
is likely a component of clathrin-coated pits. Intersectin was found
over the entire surface of the neuron including the dendrites and
axons. Exo-endocytic recycling of synaptotagmin-positive synaptic
vesicles occurs throughout all processes of the neuron at this stage in
culture (51). These results raise the interesting possibility that
intersectin-l and intersectin-s may function in the endocytosis of
synaptic vesicles and general endocytosis, respectively. Many other
proteins involved in endocytosis appear to have a similar
specialization including synaptojanin, which has a 145-kDa isoform that
is highly expressed in neurons, and a 170-kDa isoform, produced by
alternative splicing of an exon encoding a stop codon, which is widely
distributed (52, 53). In fact, AP2, clathrin, dynamin, and amphiphysin I and II are all expressed at higher levels in neuronal
versus nonneuronal cells, and many of these proteins have
neuron-specific isoforms.
The nature of the specialized function of intersectin-l in synaptic
vesicle endocytosis is difficult to predict. Intersectin-l contains DH,
PH, and C2 domains. DH domains promote guanine-nucleotide exchange on
Rho and, as is the case in intersectin-l, the DH domain is followed by
a PH domain in all guanine-nucleotide exchange factors (54). Thus,
although not tested, it is possible that intersectin-l has
guanine-nucleotide exchange factor activity that may control
Rho-dependent processes within neurons (55). PH domains
mediate interactions with inositol phospholipids (56) and C2 domains
can mediate Ca2+-dependent phospholipid binding
(57). Phospholipid metabolism, and in particular, the metabolism of
inositol phospholipids, has been strongly implicated in the endocytosis
of synaptic vesicles (58). Further, both PH and C2 domains are found in
a wide variety of proteins that function in synaptic vesicle
endocytosis including dynamin and synaptotagmin. The exact functional
role in neurons of the intersectin-l-specific C terminus remains to be explored.
The identification of intersectin-s and intersectin-l as components of
clathrin-coated pits is supported by the biochemical characterization
of intersectin protein interactions. We have previously demonstrated
that through its EH domains, intersectin interacts with mouse Ibp1 and
Ibp2 (3). We now demonstrate that Ibp2 binds to clathrin and AP2
in vitro. The importance of the interaction of Ibp2 with
clathrin/AP2 and intersectin is underscored by the observation that
both clathrin and AP2 co-immunoprecipitate with intersectin from rat
brain synaptosomes. As the isolated EH domains of intersectin appear to
be sufficient to target the protein to clathrin-coated pits, it is
tempting to speculate that Ibp2, and possibly Ibp1, mediate this
subcellular localization. Indeed, Chen et al. (5) have
suggested that epsin, the rat homologue of mouse Ibp1, may function as
a linker between the EH domains of Eps15 and clathrin-coated pit
components. The potential targeting role of the Ibps/epsins are
reminiscent of the functional role of the amphiphysins in synaptic
vesicle endocytosis as these proteins, through interactions with both
AP2 (19, 59) and clathrin (22, 48, 60), appear to target synaptojanin
and dynamin to endocytic sites (61). The Ibps/epsins appear to
represent a growing protein family as the sequence of the rat homologue of mouse Ibp2 (epsin 2) has been recently deposited in
GenBankTM (accession number AAC79495).2 The
same is true for intersectin, as two genes has been observed for mouse
(62).
Taken together, the data presented in this manuscript
suggest a role for intersectin in endocytosis. The protein is localized to clathrin-coated pits in the different cell types we have examined, where through SH3 domains, it could regulate the function of dynamin. Owen et al. (29) have recently demonstrated that the SH3
domain of amphiphysin II prevents dynamin self-assembly into rings,
thereby blocking dynamin function. In our own hands, the SH3 domains of intersectin inhibit transferrin receptor endocytosis in a
cell-permeabilized assay.3 Thus, it is possible
that intersectin functions by binding to dynamin at clathrin-coated
pits and inhibiting its access to constricted vesicular necks, its
assembly into rings, or its enzymatic activity. In neurons,
intersectin-l may have additional roles through promotion of
guanine-nucleotide exchange on Rho. Regardless of the precise mechanisms of intersectin function, the data reported here implicate the intersectin isoforms in clathrin-mediated endocytosis, both in
neurons and in nonneuronal cells.
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-adaptin (35) were generous gifts of Dr.
Margaret Robinson (Cambridge University). A monoclonal antibody against
clathrin was produced from the hybridoma X22 (ATCC) and was also kindly supplied by Dr. Mark McNiven (Mayo Clinic). A monoclonal antibody against dynamin (HUDY-1) was purchased from Upstate Biotechnology Inc.
(Albany, NY).
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
View larger version (27K):
[in a new window]
Fig. 1.
Intersectin-s localizes to
clathrin-coated pits. A, isolated plasma membranes,
prepared by sonication of COS-7 cell monolayers, were stained with an
anti-clathrin mouse monoclonal antibody (clathrin),
revealing a punctate fluorescence (37, 44). Endogenous COS-7 cell
intersectin-s displays a similar pattern as revealed with antiserum
2173. Superimposition of the images reveals a high degree of
co-localization. B, COS-7 cell plasma membranes were stained
with antiserum 2173, 2173 serum preabsorbed against the intersectin EH
domains, or 2173 serum preabsorbed against GST. All images were
captured with a Sony CCD video camera with a time integration of ~3
s. The scale bar represents 20 µm.
View larger version (23K):
[in a new window]
Fig. 2.
Recombinant intersectin and intersectin EH
domains target to clathrin-coated pits. A, plasma
membranes, isolated from COS-7 cell monolayers overexpressing
recombinant intersectin or its two EH domains
(EHa/b), were processed for immunocytochemistry
with rabbit polyclonal antibody 2173 and a mouse monoclonal antibody
against clathrin. Both full-length intersectin and the intersectin EH
domains demonstrate a similar staining pattern. Only a fraction of the
membranes that are positive for endogenous clathrin are positive for
transfected full-length intersectin or its EH domains. The images were
captured with a Sony CCD video camera with a time integration of ~300
ms. The scale bar represents 40 µm. B, at
higher magnification, double labeling immunofluorescence of plasma
membranes from transfected cells demonstrates a high degree of
co-localization between EH domain-containing constructs and clathrin.
The scale bar represents 20 µm.
View larger version (8K):
[in a new window]
Fig. 3.
Identification of long and short intersectin
proteins. A, a rat brain extract, along with extracts
from purified glial cultures and enriched neuronal cultures, were
processed for Western blots with affinity purified antibody 2173, revealing intersectin-l (~190 kDa) and intersectin-s (~145 kDa).
The weak band of ~180 kDa seen in the brain extracts is presumed to
be a proteolytic fragment of intersectin-l. B, a GST fusion
protein encoding the C-terminal 511 amino acids of Ibp2
(GST-Ibp2), encoding the EH domain-binding sites, and GST
alone (GST), were incubated with glutathione-Sepharose. The
washed beads were then incubated with soluble extracts from rat brain
(SM), and proteins specifically bound to the beads were
processed for Western blots with antibody 2173.
View larger version (17K):
[in a new window]
Fig. 4.
Tissue distribution of the intersectin
isoforms. Crude postnuclear supernatants were prepared from a
variety of tissues and cell lines and processed for Western blots with
antibody 2173.
View larger version (13K):
[in a new window]
Fig. 5.
Subcellular distribution of intersectin in
hippocampal neurons. A confocal section of intersectin staining in
a 1-day old hippocampal neuron is demonstrated in red. The
distribution of clathrin in the same field as the intersectin staining
is shown in green. Superimposition of the images
(upper right panel) demonstrates a high degree of
co-localization (yellow) of intersectin with clathrin (two
examples are indicated by the arrows). The distribution of
intersectin immunoreactivity in a CA3 pyramidal neuron cultured for 7 days reveals intersectin in Golgi-like structures as well as at the
plasma membrane (arrows, bottom panel). Scale bar
equals 10 µm.
a- and
c-isoforms of adaptin (Fig. 6A).
View larger version (15K):
[in a new window]
Fig. 6.
Ibp2 binding to clathrin and AP2 in
vitro. A, a GST fusion protein encoding the
C-terminal 511 amino acids of Ibp2 (GST-Ibp2), including
potential EH- and clathrin-binding domains, and GST alone
(GST) were incubated with glutathione-Sepharose. The washed
beads were then incubated with soluble extracts from rat brain
(SM), and proteins specifically bound to the beads were
resolved by SDS-polyacrylamide gel electrophoresis. Western blots were
reacted with an antibody against the clathrin heavy chain or the a
and
c subunits of AP2. B, to determine whether the
terminal domain of clathrin was involved in Ibp2 binding, biotinylated
forms of Ibp2, MP90, and luciferase were prepared in vitro
by coupled transcription and translation and incubated with agarose
beads prebound to two different GST fusion proteins, encoding either
the N-terminal 579 amino acids of the clathrin heavy chain
(GST-clathrinTD) or the peptide NPFL (GST-NPFL).
Proteins specifically bound to the beads were eluted with
SDS-polyacrylamide gel electrophoresis sample buffer and processed for
Western blots, along with an aliquot of the biotinylated proteins
(SM), using streptavidin-alkaline phosphatase.
View larger version (39K):
[in a new window]
Fig. 7.
Co-immunoprecipitation of clathrin, AP2, and
dynamin with intersectin. Aliquots of antisera 2173 and 2174, as
well as pre-immune 2173 antisera (NRS), were pre-coupled to
protein A-Sepharose beads for 1 h at 4 °C. Pre-coupled beads
were washed and incubated overnight at 4 °C with 1 mg of a soluble
extract prepared from rat brain synaptosomes (22) and extensively
washed the next day. Twenty µg samples of starting material
(SM) and material bound to the beads were eluted and
processed for Western blot analysis with polyclonal antibodies
against intersectin (2173) and synaptojanin, and monoclonal antibodies
against dynamin, clathrin, and the a and
c subunits of AP2. Immune complexes were detected on
separate filter strips by enhanced chemiluminescence (NEN Life
Sciences). The antigens and their approximate molecular masses (kDa)
are denoted with arrows on the right and
left sides of the figure, respectively.
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Elaine de Heuvel and Jacynthe Philie for excellent technical assistance and Dr. Wayne Sossin for on-going advice and expertise. We also thank Drs. Margaret Robinson (Cambridge University), Mark McNiven (Mayo Clinic), Todd Stukenberg (Harvard University), and James Keen (Kimmel Cancer Institute) for gifts of reagents used in this study. Glial and neuronal cell extracts were generous gifts of, respectively, Masoud Shekarabi and Dr. Tim Kennedy, and Jim Fawcett and Dr. Richard Murphy (Montreal Neurological Institute).
![]() |
FOOTNOTES |
---|
* This work was supported by Grant 197685 from the Natural Sciences and Engineering Research Council (to P. S. M.) and by a grant from the Graduate and Medical Schools of the University of Wisconsin-Madison (to B. K. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Recipient of a Medical Research Council of Canada Studentship.
Present address: NIEHS, National Institutes of Health, Bldg.
101, Rm. F346, MD F3-06, Research Triangle Park, NC 27709.
§§ To whom correspondence should be addressed: Dept. of Pharmacology, 3795 Medical Sciences Center, University of Wisconsin, 1300 University Ave., Madison, WI 53706-1532. Tel. 608-265-5218; Fax: 608-262-1257; E-mail: bkkay{at}facstaff.wisc.edu.
¶¶ Is a Scholar of the Medical Research Council of Canada and an Alfred P. Sloan Research Fellow.
2 H. Chen and P. De Camilli, unpublished data.
3 Simpson, F., Hussein, N. K., Qualmann, B., Kelly, R. B., Kay, B. K., McPherson, P. S., and Schmid, S. L. (1999) Nature Cell. Biol., in press.
![]() |
ABBREVIATIONS |
---|
The abbreviations used are: EH, Eps15 homology; DH, Dbl homology; Dap, dynamin-associated protein; GST, glutathione S-transferase; Ibp, intersectin-binding protein; MP90, mitotic phosphoprotein of 90 kDa; PH, pleckstrin homology; SH3, Src homology 3; SM, starting material; PCR, polymerase chain reaction.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|